Intercell AG
Sign in to saveIntercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna. It employs 400 people in Austria, Scotland and the United States.
Research organization · ROR
- Type
- Company
- Founded
- 1998
- Location
- Vienna, Austria
- Status
- Inactive
GRID grid.420362.1
Wikidata facts
- Instance of
- business
- Country
- Austria
- Headquarters
- Vienna
- Industry
- biotechnology
- Official website
- www.intercell.com
Show 2 more facts
- inception
- 1997-01-01
- replaced by
- Valneva SE
Sources (1)
via Wikidata · CC0
~2 min read
Encyclopedic overview
3 sectionsContents
- History
- References
- External links
Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology (IMP) in Vienna. It employs 400 people in Austria, Scotland and the United States.
== History == It was founded in 1998 and focused on the research, development, and commercialization of vaccines and other biological products. Intercell AG's products were used to prevent and treat a variety of infectious diseases, including hepatitis B, Japanese encephalitis, and pneumonia. In 2012, Intercell AG merged with Vivalis SE, a French biotech company, to form Valneva.
Excerpted from Wikipedia’s “Intercell AG” article, available under the CC BY-SA 4.0 licence.